These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 7908432)

  • 1. Abecarnil: a new beta-carboline anxiolytic preliminary clinical pharmacology.
    Duka T; Krause W; Dorow R; Rohloff A; Ott H; Voet B
    Psychopharmacol Ser; 1993; 11():132-47. PubMed ID: 7908432
    [No Abstract]   [Full Text] [Related]  

  • 2. Abecarnil, a new beta-carboline, in the treatment of anxiety disorders.
    Aufdembrinke B
    Br J Psychiatry Suppl; 1998; (34):55-63. PubMed ID: 9829018
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Abecarnil for the treatment of generalized anxiety disorder: a placebo-controlled comparison of two dosage ranges of abecarnil and buspirone.
    Pollack MH; Worthington JJ; Manfro GG; Otto MW; Zucker BG
    J Clin Psychiatry; 1997; 58 Suppl 11():19-23. PubMed ID: 9363044
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Chronic pharmacological activities of the novel anxiolytic beta-carboline abecarnil in rats.
    Ozawa M; Sugimachi K; Nakada-Kometani Y; Akai T; Yamaguchi M
    J Pharmacol Exp Ther; 1994 May; 269(2):457-62. PubMed ID: 7910208
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Human studies on abecarnil a new beta-carboline anxiolytic: safety, tolerability and preliminary pharmacological profile.
    Duka T; Schütt B; Krause W; Dorow R; McDonald S; Fichte K
    Br J Clin Pharmacol; 1993 Apr; 35(4):386-94. PubMed ID: 8097921
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Automated high-performance liquid chromatographic assay for the beta-carboline derivative Abecarnil in plasma.
    Krause W; Gröhler G
    J Chromatogr; 1989 Oct; 495():324-9. PubMed ID: 2575620
    [No Abstract]   [Full Text] [Related]  

  • 7. Antagonism of ethanol withdrawal convulsions in Withdrawal Seizure Prone mice by diazepam and abecarnil.
    Crabbe JC
    Eur J Pharmacol; 1992 Oct; 221(1):85-90. PubMed ID: 1360903
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [A pharmacological analysis of the anxiolytic action of derivations of benzodiazepine, GABA and beta-carboline in various tests of tension reaction].
    Talalaenko AN
    Farmakol Toksikol; 1989; 52(6):26-9. PubMed ID: 2576232
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Placental transfer of the anxiolytic beta-carboline abecarnil in rabbit.
    Krause W; Mechelke B
    Arzneimittelforschung; 1992 Sep; 42(9):1079-82. PubMed ID: 1359894
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Abecarnil and alprazolam reverse anxiety-like behaviors induced by ethanol withdrawal.
    Jung ME; Wallis CJ; Gatch MB; Lal H
    Alcohol; 2000 Jun; 21(2):161-8. PubMed ID: 10963939
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacokinetics and acute toleration of the beta-carboline derivative abecarnil in man.
    Krause W; Schütt B; Duka T
    Arzneimittelforschung; 1990 May; 40(5):529-32. PubMed ID: 1974428
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Interactions of the beta carboline abecarnil with the high pressure neurological syndrome in a primate model.
    Pearce PC; Halsey MJ; MacLean CJ; Passingham S; Pearson J; Mehta RL; Meldrum BS; Jordan CJ; Ward EM
    Psychopharmacology (Berl); 1992; 109(1-2):163-71. PubMed ID: 1365651
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacokinetics of the anxiolytic beta-carboline derivative abecarnil in the mouse, rat, rabbit, dog, cynomolgus monkey and baboon. Studies on species differences.
    Krause W; Mengel H
    Arzneimittelforschung; 1990 May; 40(5):522-9. PubMed ID: 1974427
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacokinetics, anticonvulsant efficacy and adverse effects of the beta-carboline abecarnil, a novel ligand for benzodiazepine receptors, after acute and chronic administration in dogs.
    Löscher W; Hönack D; Scherkl R; Hashem A; Frey HH
    J Pharmacol Exp Ther; 1990 Nov; 255(2):541-8. PubMed ID: 1978730
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The first double-blind, placebo-controlled trial of a partial benzodiazepine agonist, abecarnil (ZK 112-119), in generalized anxiety disorder.
    Ballenger JC; McDonald S; Noyes R; Rickels K; Woods SW; Patin J; Lydiard B; Garvey M; Cook B; Goodard AW
    Adv Biochem Psychopharmacol; 1992; 47():431-47. PubMed ID: 1354920
    [No Abstract]   [Full Text] [Related]  

  • 16. Abecarnil used to treat benzodiazepine withdrawal.
    Emmett-Oglesby MW; Lytle DA; English SA
    Psychopharmacol Ser; 1993; 11():121-31. PubMed ID: 7908431
    [No Abstract]   [Full Text] [Related]  

  • 17. Long-term treatment with abecarnil does not induce diazepam-like dependence in mice.
    Steppuhn KG; Schneider HH; Turski L; Stephens DN
    J Pharmacol Exp Ther; 1993 Mar; 264(3):1395-400. PubMed ID: 8095551
    [TBL] [Abstract][Full Text] [Related]  

  • 18. "Anxiolytic" action of diazepam and abecarnil in a modified open field test.
    Rex A; Stephens DN; Fink H
    Pharmacol Biochem Behav; 1996 Apr; 53(4):1005-11. PubMed ID: 8801571
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A double-blind evaluation of the safety and efficacy of abecarnil, alprazolam, and placebo in outpatients with generalized anxiety disorder. Abecarnil Work Group.
    Lydiard RB; Ballenger JC; Rickels K
    J Clin Psychiatry; 1997; 58 Suppl 11():11-8. PubMed ID: 9363043
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A double-blind comparison of abecarnil and diazepam in the treatment of uncomplicated alcohol withdrawal.
    Anton RF; Kranzler HR; McEvoy JP; Moak DH; Bianca R
    Psychopharmacology (Berl); 1997 May; 131(2):123-9. PubMed ID: 9201799
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.